Weekly Spotlight - 12.12.24

Bisphosphonates and Cinacalcet: A Hopeful Solution for Post-Transplant Challenges

Subscribe | Follow our LinkedIn page 🔗

Community

Share Your Story, Inspire Hope

Your journey can be a beacon of hope and a source of strength for others in our community. Together, we can build a stronger, more supportive community. Your story matters, and it deserves to be heard. Fill in this form to be featured.

Latest News

Bisphosphonate therapy, combined with cinacalcet, shows promise in managing post-transplant hyperparathyroidism, a common issue in kidney transplant recipients. This approach helped improve renal function and reduce complications in a patient, offering hope for better outcomes. Total parathyroidectomy further stabilised the condition, maintaining kidney health.

IgA nephropathy involves kidney damage from immune complexes with abnormally glycosylated IgA1. These complexes, bound by IgG autoantibodies, harm the kidneys, often leading to failure. Understanding these mechanisms is crucial for developing targeted treatments, as most patients face recurrent disease post-transplantation.

The SUBARU-J study examined kidney complications from anticancer drugs in Japan. It found lung cancer was most common, with tubulointerstitial nephritis and thrombotic microangiopathy frequent. Proton pump inhibitors worsened outcomes. Clinicians should note these findings to improve patient care and manage risks effectively.

Nephrotic syndrome severity is linked to gut microbiota changes. Traditional Chinese medicine (TCM) offers hope by regulating gut health, reducing inflammation, and stabilising the intestinal barrier. This approach may improve outcomes for patients, highlighting the potential of TCM in managing this challenging kidney condition.

Health Spotlight’s IgA Nephropathy is a Contentive publication in the Healthcare division